Stay updated on Pembrolizumab in Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Biliary Tract Cancer Clinical Trial page
- CheckyesterdayChange DetectedNew user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status line ("No longer looking for participants") have been added, and the Intervention/Treatment heading formatting has been updated. The revision tag changed from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check8 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a new build of the page. This appears to be a minor software/UI update with no changes to the study content or eligibility.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page shows a new revision label (v3.5.4) replacing the previous v3.5.3, indicating a deployed update to the site’s software. This update does not modify study details or data presented on the page.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a minor site/version maintenance update without changing the study details.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be an internal platform update with no visible changes to the study content.SummaryDifference0.1%

- Check87 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.